Related Experiment Video
Updated: Dec 16, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
HOPX Is an Epigenetically Inactivated Tumor Suppressor and Overexpression of HOPX Induce Apoptosis and Cell Cycle
Qinghua You1, Yuanyuan Geng1, Huiying Ye1
1Department of Pathology, Shanghai Pudong Hospital, Shanghai 201399, People's Republic of China.
Background:
Evidence has been shown that abnormal DNA methylation plays a vital role in the progression of breast cancer via silencing of gene expression. The results of bisulfite sequencing showed that the methylation status of HOPX in breast cancer tissues was higher than that in normal breast cancer tissues, but little known about the biological functions of HOPX in breast cancer.
Methods:
A total of 13 paired breast cancer and adjacent noncancerous tissues were subjected to bisulfite sequencing. Meanwhile, the methylation levels of cg218995965 and cg24862548 in breast cancer cells were detected by methylation-specific PCR (MSP). Flow cytometry, wound healing and transwell invasion assays were used to detect the apoptosis, migration and invasion in breast cancer cells. In addition, the expressions of HOPX, p21, cyclin D1 and CDK4 in cells were detected with Western blot assay.
Results:
Bisulfite sequencing indicated that the CpG sites (cg218995965 and cg24862548) in the HOPX promoter region showed significantly higher methylation in breast cancer tissues. In addition, methylation-specific PCR revealed that HOPX was significantly hypermethylated in breast cancer cell lines MDA-MB-468 and MCF-7. Furthermore, overexpression of HOPX significantly inhibited the proliferation of MDA-MB-468 and MCF-7 cells via inducing the apoptosis. Moreover, upregulation of HOPX markedly inhibited the migration and invasion abilities of MDA-MB-468 cells. Meanwhile, overexpression of HOPX obviously induced cell cycle arrest in MDA-MB-468 cells via upregulation of p21, and downregulation of cyclin D1 and CDK4. Additionally, overexpression of HOPX suppressed tumor growth of breast cancer in vivo.
Conclusion:
Our data showed that HOPX, a tumor suppressor, is epigenetically silenced in breast cancer. Overexpression of HOPX could suppress the progression of breast cancer, and thus indicating that it might serve as a potential target for the treatment of patients with breast cancer.
Insights
Homeobox Homeobox (HOPX) is epigenetically silenced in breast cancer. Restoring HOPX suppresses tumor growth, suggesting its potential as a breast cancer treatment target.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant DNA methylation is implicated in breast cancer progression by silencing gene expression.
- The methylation status of HOPX is elevated in breast cancer tissues, but its functional role remains unclear.
Purpose of the Study:
- To investigate the role of HOPX in breast cancer progression.
- To explore the potential of HOPX as a therapeutic target for breast cancer.
Main Methods:
- Bisulfite sequencing and methylation-specific PCR (MSP) to assess HOPX methylation.
- Cellular assays (flow cytometry, wound healing, Transwell) to evaluate apoptosis, migration, and invasion.
- Western blot to analyze protein expression (HOPX, p21, cyclin D1, CDK4).
Main Results:
- HOPX promoter regions (cg218995965, cg24862548) were significantly hypermethylated in breast cancer tissues and cell lines.
- Overexpression of HOPX inhibited proliferation and induced apoptosis in breast cancer cells.
- Upregulation of HOPX suppressed migration, invasion, and induced cell cycle arrest via p21, cyclin D1, and CDK4 modulation.
- HOPX overexpression inhibited tumor growth in vivo.
Conclusions:
- HOPX functions as a tumor suppressor epigenetically silenced in breast cancer.
- Restoring HOPX expression can impede breast cancer progression.
- HOPX represents a potential therapeutic target for breast cancer treatment.
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle